Cleveland Biolabs (CBLI) Reports Q2 Loss of $0.50/Share
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Total other (income)/expense: 1.85M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Total other (income)/expense: 1.85M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($0.50), versus ($0.17) reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- DBS cuts Sea target as Shopee spending weighs on profit growth
- Reaction roundup: Experts, analysts weigh in on September jobs report
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
